Home    Back

 Drug    DrugBank | All Description Patterns

   e.g. "Sirolimus", "Adalimumab"

A    B    C    D    E    F    G    H     I     J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z    other

125 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   Drug (Description in trials)   DrugBank   KEGG DRUG *   KEGG GENES * 
 [Number of genes] 		  KEGG PATHWAY 
 [Number of pathways] 		  Disease ID * 
 [Number of diseases] 
 1   20 mg bid of pf-02545920   -   -   -   -   [1]
8 
 2   20mg daily citalopram   Citalopram   D00822, D07704   [1] SLC6A4   [2] Serotonergic synapse, Synaptic vesicle cycle   [1]
8 
 3   [123i]mni-420   -   -   -   -   [2]
6,
8 
 4   [18f]fpeb   -   -   -   -   [3]
6,
8,
206 
 5   Acr16   Acr16   -   -   -   [1]
8 
 6   Acr16 10 mg   Acr16   -   -   -   [1]
8 
 7   Acr16 22.5 mg   Acr16   -   -   -   [1]
8 
 8   Acr16 45 mg   Acr16   -   -   -   [1]
8 
 9   Acr16 hydrochloride, asp2314 hydrochloride, fr310826   Acr16   -   -   -   [1]
8 
 10   Afq056   -   -   -   -   [3]
6,
8,
206 
 11   Alprazolam   Alprazolam   D00225   [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   [1]
8 
 12   Amantadine   Amantadine   D00777, D07441   [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [17] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   [4]
6,
8,
13,
127 
 13   Atomoxetine   Atomoxetine   D02574, D07473   [1] SLC6A2   [1] Synaptic vesicle cycle   [3]
6,
8,
13 
 14   Autologous stem cell   -   -   -   -   [1]
8 
 15   Bevantolol   Bevantolol   -   -   -   [1]
8 
 16   Bevantolol hydrochloride   Bevantolol   -   -   -   [1]
8 
 17   Blood sample   -   -   -   -   [12]
8,
13,
46,
49,
51,
53,
61,
66,
97,
274,
288,
299 
 18   Bn82451b   -   -   -   -   [1]
8 
 19   Bn8251b   -   -   -   -   [1]
8 
 20   Bupropion   Bupropion   D00817, D07591, D07938   [2] SLC6A2, SLC6A3   [6] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Synaptic vesicle cycle   [2]
8,
96 
 21   Calvan® 100 mg   -   -   -   -   [1]
8 
 22   Cellavita hd higher dose   -   -   -   -   [1]
8 
 23   Cellavita hd lower dose   -   -   -   -   [1]
8 
 24   Citalopram   Citalopram   D00822, D07704   [1] SLC6A4   [2] Serotonergic synapse, Synaptic vesicle cycle   [3]
8,
46,
127 
 25   Coenzyme q10   Ubidecarenone   D01065   -   -   [10]
2,
6,
8,
10,
46,
57,
113,
193,
214,
215 
 26   Coq10   Ubidecarenone   D01065   -   -   [3]
5,
6,
8 
 27   Creatine   Creatine   -   -   -   [12]
1,
2,
5,
6,
8,
13,
46,
49,
50,
113,
156,
201 
 28   Creatine monohydrate   Creatine   -   -   -   [4]
2,
8,
113,
156 
 29   Cystagon   Cysteamine   D03634, D03635   -   -   [3]
8,
19,
299 
 30   Cysteamine   Cysteamine   D03634, D03635   -   -   [4]
8,
19,
21,
299 
 31   Cysteamine bitartrate   Cysteamine   D03634, D03635   -   -   [4]
8,
19,
21,
299 
 32   Dextromethorphan   Dextromethorphan   D00848, D03742, D03744   [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [17] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   [9]
2,
6,
8,
13,
46,
78,
96,
97,
156 
 33   Dextromethorphan/quinidine 20mg/10mg (dm/q 20mg/10mg)   Dextromethorphan   D00848, D03742, D03744   [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [17] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   [1]
8 
 34   Digoxin   Digoxin   D00298   [4] ATP1A1, ATP1A2, ATP1A3, ATP1A4   [18] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway   [2]
8,
46 
 35   Dimebon   Latrepirdine   D09917   [6] ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [19] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   [1]
8 
 36   Dimebon (latrepirdine)   Latrepirdine   D09917   [6] ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [19] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   [1]
8 
 37   Dimebon + dextromethorphan   Dextromethorphan   D00848, D03742, D03744   [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [17] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   [1]
8 
 38   Dimebon + ketoconazole   Ketoconazole   D00351   [1] CYP17A1   [6] Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis   [1]
8 
 39   Dimebon + omeprazole   Omeprazole   D00455, D01207, D05259, D05261   [2] ATP4A, ATP4B   [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation   [1]
8 
 40   Dimebon alone   Latrepirdine   D09917   [6] ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [19] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   [1]
8 
 41   Dimebon dihydrochloride   Latrepirdine   D09917   [6] ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [19] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   [1]
8 
 42   Dimebon ir   Latrepirdine   D09917   [6] ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [19] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   [1]
8 
 43   Dimebon ir tablet   Latrepirdine   D09917   [6] ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [19] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   [1]
8 
 44   Dimebon mr1   Latrepirdine   D09917   [6] ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [19] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   [1]
8 
 45   Dimebon mr2   Latrepirdine   D09917   [6] ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [19] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   [1]
8 
 46   Dimebon mr3   Latrepirdine   D09917   [6] ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [19] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   [1]
8 
 47   Dimebon mr4   Latrepirdine   D09917   [6] ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [19] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   [1]
8 
 48   Dimebon transdermal   Latrepirdine   D09917   [6] ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [19] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   [1]
8 
 49   Divalproex   Valproic acid   D00399   [7] ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2   [17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism   [1]
8 
 50   Ethyl-epa   Icosapent ethyl   D01892   -   -   [1]
8 
 51   Ethyl-epa (miraxion™)   Icosapent ethyl   D01892   -   -   [1]
8 
 52   Fenofibrate   Fenofibrate   D00565   [1] PPARA   [7] Adipocytokine signaling pathway, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease (NAFLD), PPAR signaling pathway, cAMP signaling pathway   [5]
8,
79,
93,
94,
265 
 53   Graft intracerebral of foetal neurons   -   -   -   -   [1]
8 
 54   Gsk356278   Gsk356278   -   -   -   [1]
8 
 55   Haloperidol   Haloperidol   D00136, D01898   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
8 
 56   Hyperium   Rilmenidine   D08482   [3] ADRA2A, ADRA2B, ADRA2C   [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   [1]
8 
 57   Isis 443139 10 mg   -   -   -   -   [1]
8 
 58   Isis 443139 120 mg   -   -   -   -   [1]
8 
 59   Isis 443139 30 mg   -   -   -   -   [1]
8 
 60   Isis 443139 60 mg   -   -   -   -   [1]
8 
 61   Isis 443139 90 mg   -   -   -   -   [1]
8 
 62   Ketoconazole   Ketoconazole   D00351   [1] CYP17A1   [6] Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis   [3]
8,
13,
75 
 63   Laquinimod   Laquinimod   -   -   -   [4]
8,
13,
49,
96 
 64   Latrepirdine   Latrepirdine   D09917   [6] ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [19] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   [1]
8 
 65   Lax-101   -   -   -   -   [1]
8 
 66   Lithium   Lithium citrate   D04749   -   -   [4]
2,
5,
7,
8 
 67   Memantine   Memantine   D04905, D08174   [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [17] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   [7]
2,
6,
8,
13,
49,
127,
205 
 68   Minocycline   Minocycline   D00850, D05045   -   -   [13]
2,
6,
8,
13,
46,
85,
90,
94,
162,
201,
206,
280,
299 
 69   N.a.   -   -   -   -   [8]
3,
6,
8,
13,
46,
97,
240,
256 
 70   Neflamapimod   Neflamapimod   D10959   [4] MAPK11, MAPK12, MAPK13, MAPK14   [53] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis (ALS), C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease (American trypanosomiasis), Dopaminergic synapse, Endocrine resistance, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hepatitis B, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, IL-17 signaling pathway, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, MAPK signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Oocyte meiosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pertussis, Platelet activation, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Relaxin signaling pathway, Retrograde endocannabinoid signaling, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Yersinia infection   [1]
8 
 71   Nilotinib   Nilotinib   D08953   [4] ABL1, KIT, PDGFRA, PDGFRB   [33] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Shigellosis, Viral myocarditis   [5]
6,
8,
34,
51,
86 
 72   Nilotinib 150 mg   Nilotinib   D08953   [4] ABL1, KIT, PDGFRA, PDGFRB   [33] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Shigellosis, Viral myocarditis   [1]
8 
 73   Olanzapine   Olanzapine   D00454, D06623   [11] ADRA1A, ADRA1B, ADRA1D, DRD2, DRD3, DRD4, HRH1, HTR2A, HTR2B, HTR2C, HTR6   [16] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Salivary secretion, Serotonergic synapse, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   [2]
2,
8 
 74   Omeprazole   Omeprazole   D00455, D01207, D05259, D05261   [2] ATP4A, ATP4B   [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation   [15]
6,
8,
13,
46,
51,
85,
96,
97,
98,
225,
271,
282,
294,
298,
299 
 75   Osu6162 similar to (-)-osu 6162   -   -   -   -   [2]
6,
8 
 76   Pbf-999   -   -   -   -   [1]
8 
 77   Pbf-999 / 160 mg   -   -   -   -   [1]
8 
 78   Pbf-999 / 320 mg   -   -   -   -   [1]
8 
 79   Pbt2   -   -   -   -   [1]
8 
 80   Pf-02545920   -   -   -   -   [1]
8 
 81   Phenylbutyrate   Phenylbutyric acid   D05868   -   -   [10]
2,
3,
6,
8,
93,
94,
244,
251,
297,
299 
 82   Phosphorus   Phosphorus   -   -   -   [1]
8 
 83   Pridopidine   Pridopidine   D09953   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [2]
6,
8 
 84   Pridopidine (90 mg)   Pridopidine   D09953   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
8 
 85   Quinidine   Quinidine   D00642, D00643, D02272, D08458   [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   [3]
2,
8,
13 
 86   Ramelteon   Ramelteon   D02689   [2] MTNR1A, MTNR1B   [2] Circadian entrainment, Neuroactive ligand-receptor interaction   [3]
6,
8,
46 
 87   Resveratrol   Resveratrol   -   -   -   [3]
8,
89,
113 
 88   Rg6042, formerly isis 443139, ionis-httrx   -   -   -   -   [1]
8 
 89   Rilmenidine   Rilmenidine   D08482   [3] ADRA2A, ADRA2B, ADRA2C   [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   [1]
8 
 90   Riluzole   Riluzole   D00775   [14] GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway   [7]
2,
3,
5,
8,
13,
17,
206 
 91   Risperidone   Risperidone   D00426   [2] DRD2, HTR2A   [11] Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway   [5]
8,
156,
179,
187,
206 
 92   Ro 723-4292/f02   -   -   -   -   [1]
8 
 93   Ro7234292   -   -   -   -   [1]
8 
 94   Ro7234292 (rg6042)   -   -   -   -   [1]
8 
 95   Rolipram   Rolipram   D01783   [4] PDE4A, PDE4B, PDE4C, PDE4D   [5] Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway   [2]
8,
13 
 96   Rp 103   -   -   -   -   [2]
8,
19 
 97   Rp103   -   -   -   -   [2]
8,
19 
 98   Sage   Sage   -   -   -   [2]
6,
8 
 99   Sage-718   Sage   -   -   -   [1]
8 
 100   Sbt-020   -   -   -   -   [1]
8 
 101   Sd-809   -   -   -   -   [1]
8 
 102   Selisistat   Selisistat   -   -   -   [1]
8 
 103   Sen0014196   -   -   -   -   [1]
8 
 104   Sodium phenylbutyrate   Phenylbutyric acid   D05868   -   -   [4]
2,
3,
8,
251 
 105   Som3355 100mg bid   -   -   -   -   [1]
8 
 106   Som3355 200mg bid   -   -   -   -   [1]
8 
 107   Srx246   -   -   -   -   [1]
8 
 108   Ss-20   -   -   -   -   [1]
8 
 109   Tetrabenazine   Tetrabenazine   D08575   [1] SLC18A2   [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle   [1]
8 
 110   Tetrabenazine withdrawal   Tetrabenazine   D08575   [1] SLC18A2   [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle   [1]
8 
 111   Tiapridal   -   -   -   -   [1]
8 
 112   Triheptanoin   Triheptanoin   D11465   -   -   [10]
2,
8,
120,
149,
156,
248,
256,
257,
317,
324 
 113   Triheptanoin 1g/kg/day   Triheptanoin   D11465   -   -   [1]
8 
 114   Triheptanoin oil   Triheptanoin   D11465   -   -   [1]
8 
 115   Tv-7820   -   -   -   -   [1]
8 
 116   Ubiquinol   Ubiquinol   -   -   -   [3]
6,
8,
17 
 117   Ursodiol   Ursodeoxycholic acid   D00734   [1] NR1H4   [1] Bile secretion   [6]
8,
20,
93,
97,
234,
299 
 118   Ux007   -   -   -   -   [4]
8,
248,
256,
257 
 119   Valbenazine   Valbenazine   D10675   [1] SLC18A2   [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle   [1]
8 
 120   Vx15/2503   Pepinemab   D11469   [1] SEMA4D   [1] Axon guidance   [2]
8,
13 
 121   Warfarin   Warfarin   D00564, D01280, D08682   [2] NQO1, VKORC1   [5] Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis   [10]
6,
8,
13,
19,
46,
49,
66,
85,
88,
96 
 122   Wve-120101   -   -   -   -   [1]
8 
 123   Wve-120102   -   -   -   -   [1]
8 
 124   Xenazine   Tetrabenazine   D08575   [1] SLC18A2   [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle   [1]
8 
 125   Zoloft   Sertraline   D00825, D02360   [1] SLC6A4   [2] Serotonergic synapse, Synaptic vesicle cycle   [1]
8 

Back to top